The elderly are often plagued with many age-related diseases that impact their lives including movement and ability to make a better judgment. For many of them, these conditions contribute to some limitation in life as it takes a toll on their well being. Age-related disorders also increase the mortality rate of the elderly. Researchers, scientists, donors and medical practitioners have collaborated to help in reversing the aging process to overcome degenerative health issues.
Jason Hope is one such individual who has contributed to the research of age-related diseases by investing in biotechnology company called SENS Research Foundation. The non-profit foundation is committed to using innovative biotechnologies to develop anti-ageing medicine and therapy. Hope donated $500,000 to support the initiative that catered toward AGE-breaker research programs that aim at developing drugs in addition to treatment that will help to prevent the growth of metabolic wastes in the human body.
One of the primary causes of age-related diseases is the buildup of glycation end-products. This happens faster in people who have diabetes. It also happens to everyone and causes a lot of harm in the cells. AGEs disable the protein machinery by hammering on cell receptors that cause chronic inflammation. Initially, AGE-breaker drugs occurred before the current era of biotechnology development. It was not only laborious but sparingly used in patients regardless of promising animal studies. The research turned out to be necessary to humans.
According to Jason Hope, SENS Research Foundation is one of the organizations that can reduce the development of age-related diseases such as cancer, Alzheimer’s and arthritis among others. These infections are common in older people because of their slow metabolism. Hope’s contribution has inspired many researchers and donors to join the program and donate funds toward finding treatment solutions to prevent patients from acquiring these diseases.
Jason Hope grew up in Arizona. He joined Arizona State University for a degree in finance before heading to Carey School of Business for an MBA. He started working as an entrepreneur, philanthropist as well as an investor. Jason Hope would later work as consultant for different businesses across the state of Arizona.
To Read More Click This Link : www.sens.org/outreach/press-releases/jason-hope-pledges-500000
While many may only know that Eric Lefkofsky is an American billionaire, what some may not know is that he is also heavily involved in philantrophy. Lefkofsky has his hand in many different business ventures due to the fact that early in life he became an entrepreneur with strong business instincts; however, those are also the same instincts that have given him the know how to give millions to multiple charities and to form a charitable trust called, the Lefkofsky Foundation.
The Lefkofsky foundation is a foundation that Eric and his wife started in 2006, as an effort to give back to the community with hopes of changing the lives of others for the better. The purpose of the foundation is to fund as any initiatives as possible that are considered to be high impact initiatives. The foundation focuses its attention to programs and initiatives that address educational issues, human rights, medical research, and cultural movements.
Eric and his wife Liz have a deep love for educational initiatives and firmly believe that obtaining a quality education is a right that everyone should have. It is because of this belief that the foundation has funded many initiatives when it comes to education including the High School Bound program and the Success Bound program. When it comes to medical research funding, cancer research gets a large chunk of donations and this is because Liz lost her sister to cancer and both Liz and her mother are cancer survivors, so better cancer research is something that Liz firmly believes in.
Eric Lefkofsky without a doubt loves his community and believes in giving back to others. With people like him giving to others, there is still hope for the human race.
To Learn More Click Here
Over the past few years, the general population has witnessed an increase in the number of cancer survivors. The surge is a result of the expansion of cancer services, screening efforts, and breakthrough cancer research. Furthermore, cancer treatments centers are now better equipped. A report from the Surveillance, Epidemiology and End Results program show remarkable statistics of the number of cancer survivors’ population. The results of the extensive research show an increase to over fifteen million in 2016. This is almost four times the number just three decades ago.
However, we would not be talking about such improvement without the helping hand of scientific research. The brains behind fighting cancer are overlooked while they toil to find a cure for this menace. One such character who is outstanding is Eric Lefkofsky. The co-founder of Tempus is spearheading the lead in developing the next generation technology to modernize cancer treatment. The health-startups help the physician to provide the right prescription for their cancer patients.
The 48-year old is the head of Tempus, the company battling cancer. He attributes his drive to fighting cancer to the experience of a close relative undergoing cancer treatment. He combines his efforts with several scientists in the field, while also collaborating with hospitals on advancements in cancer treatment. Through their state-of-the-art facilities, they help identify the genomic data of a patient providing their data science. The information is critical in picking the correct clinical care for the patient.
Additionally, Eric is an avid philanthropist towards cancer research and development. His foundation regularly donates to cancer research institutions and universities. This shows his actual goal of investing in tackling cancer on behalf of humanity. He argues that medical discoveries should be more critical, and advanced health infrastructure will be the key to precision medicine. As his efforts begin to bear fruit, Eric believes big data as a tool that is somewhat underutilized even though it will be one way of moving forward. With the number of cancer survivors increasing, understanding nature of cancer is a vital aspect in determining the success of the clinical trials.
To Learn More Click Here